DR Congo begins Ebola vaccination trials for frontline health workers

The Democratic Republic of Congo has initiated vaccine trials aimed at protecting health workers who are responding to the nation's current Ebola outbreak. The programme focuses on frontline medical personnel, a group that faces heightened exposure during outbreaks and plays a central role in patient care and outbreak control.

Officials implementing the trials are using Ervebo, a vaccine that has been deployed in past Ebola responses. Health authorities hope that its prior use will provide a useful basis for assessing whether it can protect against the particular Ebola strain involved in the present crisis.

The trial rollout represents a targeted approach to vaccination, concentrating on those most likely to encounter infected patients. By prioritising health workers, the initiative seeks to both lower infection risk among medical staff and help preserve healthcare capacity during the emergency.

Authorities will monitor the vaccine's performance in this context to determine effectiveness against the circulating strain. The outcomes of these trials will inform decisions about broader use of the vaccine as the outbreak response continues.